This article provides a comprehensive analysis for researchers and drug development professionals on the critical challenge of controlling dedifferentiation in cellular rejuvenation therapies.
This article provides a comprehensive analysis for researchers and drug development professionals on leveraging epigenetic reprogramming to prevent cancer initiation.
This article comprehensively reviews the rapidly advancing field of chemical reprogramming, a non-genetic approach for generating human induced pluripotent stem cells (iPSCs) using small molecules.
This article provides a comprehensive analysis of the rapidly evolving field of biomaterial-mediated delivery of epigenetic modulators.
The extracellular matrix (ECM) is no longer viewed as merely a structural scaffold; its mechanical properties, particularly rigidity, are now recognized as potent regulators of the cellular epigenome.
This article explores the transformative role of three-dimensional (3D) microenvironments in enhancing the efficiency and functionality of cellular reprogramming.
This article provides a comprehensive analysis of current methods for delivering Yamanaka factors (OCT4, SOX2, KLF4, c-MYC) for in vivo reprogramming, a transformative approach in regenerative medicine.
This article provides a comprehensive overview of the rapidly advancing field of epigenetic reprogramming using small molecules.
This article explores the pivotal role of non-coding RNAs (ncRNAs) as master regulators of the epigenetic landscape in cell reprogramming and regenerative medicine.
This article provides a comprehensive analysis of partial cellular reprogramming as a transformative strategy for tissue regeneration.